ARTICLE | Company News
BioInvent licenses Thymon's HIV antibody patents
July 18, 2002 7:00 AM UTC
BioInvent (SSE:BINV) acquired rights to patents for therapeutic monoclonal antibodies against the HIV-1 Tat protein from Thymon (Short Hills, N.J.). BINV plans to develop antibody-based therapeutics t...